Advanced Flower Capital Inc. Quarterly Current State and Local Tax Expense (Benefit) in USD from Q1 2023 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Advanced Flower Capital Inc. quarterly/annual Current State and Local Tax Expense (Benefit) history and growth rate from Q1 2023 to Q2 2025.
  • Advanced Flower Capital Inc. Current State and Local Tax Expense (Benefit) for the quarter ending June 30, 2025 was -$43K, a 142% decline year-over-year.
  • Advanced Flower Capital Inc. Current State and Local Tax Expense (Benefit) for the twelve months ending June 30, 2025 was $165K, a 56.9% decline year-over-year.
  • Advanced Flower Capital Inc. annual Current State and Local Tax Expense (Benefit) for 2024 was $299K, a 2.43% decline from 2023.
  • Advanced Flower Capital Inc. annual Current State and Local Tax Expense (Benefit) for 2023 was $306K, a 53.2% increase from 2022.
Current State and Local Tax Expense (Benefit), Trailing 12 Months (USD)
Current State and Local Tax Expense (Benefit), Quarterly (USD)
Current State and Local Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 $165K -$43K -$146K -142% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-14
Q1 2025 $311K $65K +$11.9K +22.5% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-14
Q4 2024 $299K $42.9K +$15.9K +59.1% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-13
Q3 2024 $283K $100K -$100K -50% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $383K $103K +$66.9K +185% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-14
Q1 2024 $316K $53.1K +$9.76K +22.5% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-14
Q4 2023 $306K $26.9K Oct 1, 2023 Dec 31, 2023 10-K 2025-03-13
Q3 2023 $200K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $36.1K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $43.3K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.